Distinct immunological mechanisms of CTLA-4 and PD-1 blockade revealed by analyzing TCR usage in blood lymphocytes-Reference-Cited by-同舟云学术

Distinct immunological mechanisms of CTLA-4 and PD-1 blockade revealed by analyzing TCR usage in blood lymphocytes

Published:2014-06 Issue:6 Volume:3 Page:e29244
ISSN:2162-402X
Container-title:OncoImmunology
language:en
Short-container-title:OncoImmunology

Author:

Robert Lidia,Harview Christina,Emerson Ryan,Wang Xiaoyan,Mok Stephen,Homet Blanca,Comin-Anduix Begonya,Koya Richard C,Robins Harlan,Tumeh Paul C,Ribas Antoni

Publisher

Informa UK Limited

Subject

Oncology,Immunology,Immunology and Allergy

Link

http://www.tandfonline.com/doi/pdf/10.4161/onci.29244

Reference10 articles.

1. Ipilimumab plus Dacarbazine for Previously Untreated Metastatic Melanoma

2. Phase III Randomized Clinical Trial Comparing Tremelimumab With Standard-of-Care Chemotherapy in Patients With Advanced Melanoma

3. Safety, Activity, and Immune Correlates of Anti–PD-1 Antibody in Cancer

4. Safety and Tumor Responses with Lambrolizumab (Anti–PD-1) in Melanoma

5. Survival, Durable Tumor Remission, and Long-Term Safety in Patients With Advanced Melanoma Receiving Nivolumab

Cited by 84 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Analysis of Wilms’ tumor protein 1 specific TCR repertoire in AML patients uncovers higher diversity in patients in remission than in relapsed;Annals of Hematology;2024-09-11

2. Personalized neoantigen vaccine and pembrolizumab in advanced hepatocellular carcinoma: a phase 1/2 trial;Nature Medicine;2024-04

3. Tumor-infiltrating lymphocytes as a prognostic and predictive factor for Melanoma;Expert Review of Molecular Diagnostics;2024-02-05

4. Biomarkers and experimental models for cancer immunology investigation;MedComm;2023-12

5. Opportunities and challenges of liquid biopsy in liver cancer;Clinical Surgical Oncology;2023-12